The Pharmaceutical industry is composed of patented, branded prescription/ethical drugs (Rx) and of unpatented prescription drugs sold under a chemical name or a brand name (Gx). These drugs can be treatments for an existing disease (therapeutics) or treatments to prevent the onset of that disease (prophylactics). There are many modalities for these drugs, including small molecules/pills and vaccines. They can be taken orally, intravenously, nasal spray, inhalation and injection amongst others. The pharma business is global with companies of all sizes in practically every country in the world.
Ferghana advises its clients on strategic Partnerships, Acquisitions and Divestments, as well as on creative Financings, since these elements are all critical to the healthy future and growth of pharmaceutical companies.
Ferghana balances its expertise between the rigorous mastery of transactional processes, a seasoned understanding of the industrial context, and a deep grounding in the scientific and clinical development underpinnings in these therapeutic areas:
- INFECTIOUS DISEASE
- METABOLIC DISEASES
- REGENERATIVE MEDICINE
- Reproductive Health
Drug Delivery technology offers ways in which therapeutic and prophylactic compounds can be more effectively delivered, thereby enhancing patient compliance and convenience, extending the patentable life of the drug and increasing efficacy with fewer side effects. Of the numerous delivery methods available to administer drugs, Ferghana has extensive knowledge of most of them such as these:
- EXTENDED RELEASE
- ORAL DELIVERY